• Tamoor Bin Hanif
  • Jaleel Anwar
  • Muhammad Idrees


Background: Detection of protein C and S deficiency forms a major investigation in thelaboratory evaluation of thrombophilia screening. It has key role in the diagnosis of protein C andS deficiency. The objective of this study is to determine the utility of ProC Global as a screeningtest for identifying the defects of protein C and S anticoagulant pathways. Methods: TwoHundred patients with venous thromboembolism were studied at the Department of Haematology,Armed Forces Institute of Pathology, Rawalpindi, from October 2004 to March 2006. ProC Globaltest (Dade Behring Diagnostics) was performed and was followed up by protein C and S assays.ProC Global is an activated partial thromboplastin time based assay in which Protac (snake venomfrom Aghistroden contortrix) is used for activation of the endogenous protein C of the plasmasample. The protein C activation time in the presence of the activator was set in relation to aparallel determination of PCAT/O with addition of a buffer instead of activator reagent. The ratioPCAT: PCAT/O was transformed in normalized ratio by relating them to a calibrator. Controlplasma for normal range and ProC control plasma for pathological range (Dade BehringDiagnostics) were assayed in each run for quality control. Results: A total of 200 patients, 132(66%) males and 68 (34%) females with age ranging from 1 to 68 years were studied. ProC Globalwas positive in 29/200 (14.5%) patients. ProC Global was found to be 86% sensitive, 94% specificand its overall efficiency turned out to be 94%. Conclusion: Pro-C Global can be used effectivelyas a screening test to detect abnormalities in protein C and S anticoagulant pathways.Keywords: Protein C deficiency, Protein S deficiency, Thrombophilia


Soare AM, Popa C. Deficiencies of proteins C, S and

antithrombin and activated protein C resistance–their

involvement in the occurrence of Arterial thromboses. J Med

Life 2010;3:412–5.

Meinardi JR, van der Schaaf W, Bom FH, van der Meer J. A

new screening test for the Protein C anticoagulant pathway:

The PCP test. Fibrinolysis 1999;13:16–20.

Bereczky Z, Kovács KB, Muszbek L. Protein C and protein S

deficiencies: similarities and differences between two

brothers playing in the same game. Clin Chem Lab Med


Soare AM, Popa C. Deficiencies of proteins C, S and

antithrombin and factor V Leiden and the risk of ischemic

strokes. J Med Life 2010;3:235–8.

Hunt BJ, Greaves M. Acquired venous thrombosis. In:

Hoffbrand AV, Catovsky D, Tuddenham EGD, (editors).

Postgraduate Haematology. 5th ed. Massachusetts: Blackwell

Publishing; 2005.p. 900–11.

Antonanzas F, Rodriguez-Ibeas R, Hutter MF, Lorente R,

Juarez C, Pinillos M. Genetic testing in the European Union:

does economic evaluation matter? Eur J Health Econ. 2011;



Most read articles by the same author(s)